Advertisement
News
Advertisement

Abiomed gets FDA OK for Impella device

Mon, 09/10/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Abiomed Inc. (Nasdaq:ABMD) received approval by the U.S. Food and Drug Administration (FDA) for a new catheter-based Impella device that provides four liters of blood per minute.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading